Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial
Harald Prüß(German Center for Neurodegenerative Diseases), Jan M. Schwab(The Ohio State University Wexner Medical Center), Oliver Wengert(Charité - Universitätsmedizin Berlin), Karsten Gronert(University of California, Berkeley), Aaron B. Sullivan(University of California, Berkeley), Benedikt Brommer(CellAct Pharma (Germany)), Berit Rosche(Charité - Universitätsmedizin Berlin)
Cited by 107
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
|Neurology Neuroimmunology & Neuroinflammation|2021|702
N‐methyl‐<scp>D</scp>‐aspartate receptor antibodies in herpes simplex encephalitis
|Annals of Neurology|2012|414